| Dec 7, 2025 |
Dec 9, 2025 |
OmniAb, Inc.
|
Chief Legal Officer |
Sell |
46.3
|
-8,044
|
-2.09%
|
✗
|
$15.8K |
| Apr 7, 2025 |
Apr 7, 2025 |
OmniAb, Inc.
|
Chief Legal Officer |
Sell |
46.3
|
-7,206
|
-1.95%
|
✗
|
$14.4K |
| Feb 15, 2025 |
Feb 19, 2025 |
OmniAb, Inc.
|
Chief Legal Officer |
Sell |
42.5
|
-15,470
|
-4.15%
|
✗
|
$56.9K |
| Jan 17, 2025 |
Jan 22, 2025 |
OmniAb, Inc.
|
Chief Legal Officer |
Sell |
90.0
|
+19,805
|
6.12%
|
✗
|
$82.6K |
| Dec 7, 2024 |
Dec 10, 2024 |
OmniAb, Inc.
|
Chief Legal Officer |
Sell |
46.3
|
-8,022
|
-2.42%
|
✗
|
$33.1K |
| Apr 7, 2024 |
Apr 9, 2024 |
OmniAb, Inc.
|
Chief Legal Officer |
Sell |
46.3
|
-6,954
|
-2.32%
|
✗
|
$36.6K |
| Feb 15, 2024 |
Feb 20, 2024 |
OmniAb, Inc.
|
Chief Legal Officer |
Sell |
46.3
|
-7,609
|
-1.32%
|
✗
|
$42.2K |
| Jan 2, 2024 |
Jan 3, 2024 |
OmniAb, Inc.
|
Chief Legal Officer |
Sell |
46.3
|
-7,195
|
-2.57%
|
✗
|
$45K |
| Dec 7, 2023 |
Dec 11, 2023 |
OmniAb, Inc.
|
Chief Legal Officer |
Sell |
46.3
|
-5,403
|
-2.02%
|
✗
|
$26.2K |
| Feb 15, 2023 |
Feb 17, 2023 |
OmniAb, Inc.
|
Chief Legal Officer |
Sell |
46.3
|
-9,543
|
-2.49%
|
✗
|
$36.3K |
| Dec 28, 2022 |
Dec 30, 2022 |
OmniAb, Inc.
|
Officer |
Sell |
26.3
|
-6,518
|
-1.90%
|
✗
|
$23.9K |
| Dec 1, 2022 |
Dec 5, 2022 |
OmniAb, Inc.
|
Officer |
Sell |
26.3
|
-10,580
|
-2.99%
|
✗
|
$35.4K |
| Feb 15, 2022 |
Feb 16, 2022 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Sell |
42.5
|
-1,578
|
-4.94%
|
✗
|
$195.2K |
| Jan 26, 2022 |
Jan 28, 2022 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Sell |
95.0
|
+4,081
|
14.63%
|
✗
|
$245.1K |
| Feb 15, 2021 |
Feb 18, 2021 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Sell |
42.5
|
-1,015
|
-3.51%
|
✗
|
$175K |
| Feb 3, 2021 |
Feb 5, 2021 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Sell |
17.5
|
-14,606
|
-33.57%
|
✗
|
$3.2M |
| Jan 25, 2021 |
Jan 27, 2021 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Sell |
90.0
|
+2,397
|
5.83%
|
✗
|
$208.9K |
| Jun 30, 2020 |
Jul 1, 2020 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Buy |
68.8
|
+238
|
0.58%
|
✗
|
$21.2K |
| Jun 4, 2020 |
Jun 5, 2020 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Sell |
17.5
|
-11,146
|
-21.43%
|
✗
|
$1.3M |
| Feb 13, 2020 |
Feb 18, 2020 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Sell |
90.0
|
+2,954
|
6.02%
|
✗
|
$85.7K |
| Dec 20, 2019 |
Dec 26, 2019 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Sell |
87.5
|
+1,897
|
4.02%
|
✗
|
$119.7K |
| Jun 28, 2019 |
Jul 2, 2019 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Buy |
61.3
|
+182
|
0.40%
|
✗
|
$17.7K |
| Sep 17, 2018 |
Sep 18, 2018 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Sell |
26.3
|
-2,813
|
-9.20%
|
✓
|
$705.2K |
| Sep 4, 2018 |
Sep 5, 2018 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Sell |
5.0
|
-19,417
|
-41.16%
|
✓
|
$5M |
| Jun 29, 2018 |
Jul 3, 2018 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Buy |
68.8
|
+180
|
0.65%
|
✗
|
$21.2K |
| Mar 2, 2018 |
Mar 6, 2018 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Sell |
95.0
|
+2,524
|
10.07%
|
✗
|
$65K |
| Feb 15, 2018 |
Feb 16, 2018 |
LIGAND PHARMACEUTICALS INC
|
SVP, Gen. Counsel & Secretary |
Sell |
42.5
|
-1,036
|
-3.97%
|
✗
|
$162.8K |
| Dec 28, 2017 |
Dec 29, 2017 |
LIGAND PHARMACEUTICALS INC
|
VP, Gen. Counsel & Secretary |
Sell |
90.0
|
+1,672
|
6.85%
|
✗
|
$162.9K |
| Aug 9, 2017 |
Aug 10, 2017 |
LIGAND PHARMACEUTICALS INC
|
VP, Gen. Counsel & Secretary |
Sell |
17.5
|
-18,625
|
-43.27%
|
✗
|
$2.4M |
| Jun 30, 2017 |
Jul 5, 2017 |
LIGAND PHARMACEUTICALS INC
|
VP, Gen. Counsel & Secretary |
Buy |
68.8
|
+243
|
0.57%
|
✗
|
$21.2K |
| Aug 5, 2016 |
Aug 9, 2016 |
LIGAND PHARMACEUTICALS INC
|
VP, Gen. Counsel & Secretary |
Sell |
17.5
|
-22,067
|
-19.88%
|
✗
|
$2.7M |
| Jul 10, 2015 |
Jul 14, 2015 |
LIGAND PHARMACEUTICALS INC
|
VP, Gen. Counsel & Secretary |
Sell |
5.0
|
-14,067
|
-34.72%
|
✓
|
$1.4M |
| Jun 30, 2015 |
Jul 1, 2015 |
LIGAND PHARMACEUTICALS INC
|
VP, Gen. Counsel & Secretary |
Buy |
78.8
|
+465
|
1.79%
|
✗
|
$21.2K |
| Mar 16, 2015 |
Mar 18, 2015 |
LIGAND PHARMACEUTICALS INC
|
VP, Gen. Counsel & Secretary |
Sell |
20.0
|
-11,264
|
-12.62%
|
✗
|
$839.6K |
| Dec 31, 2014 |
Mar 18, 2015 |
LIGAND PHARMACEUTICALS INC
|
VP, Gen. Counsel & Secretary |
Buy |
60.0
|
+126
|
0.46%
|
✗
|
$5.7K |
| Dec 31, 2014 |
Jan 5, 2015 |
LIGAND PHARMACEUTICALS INC
|
VP, Gen. Counsel & Secretary |
Buy |
60.0
|
+126
|
0.46%
|
✗
|
$5.7K |
| Jun 30, 2014 |
Jul 1, 2014 |
LIGAND PHARMACEUTICALS INC
|
VP, Gen. Counsel & Secretary |
Buy |
78.8
|
+329
|
1.22%
|
✗
|
$14.4K |
| May 27, 2014 |
May 28, 2014 |
LIGAND PHARMACEUTICALS INC
|
VP, Gen. Counsel & Secretary |
Sell |
20.0
|
-7,166
|
-6.23%
|
✗
|
$479.4K |
| Feb 12, 2014 |
Feb 14, 2014 |
LIGAND PHARMACEUTICALS INC
|
VP, Gen. Counsel & Secretary |
Sell |
17.5
|
-12,381
|
-5.00%
|
✗
|
$1.1M |